Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population
- PMID: 29478365
- DOI: 10.1080/00325481.2018.1444901
Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population
Abstract
Objectives: Adiposity, defined by higher cardiometabolic index (CMI), lipid accumulation product (LAP), and body adiposity index (BAI), has conferred increased metabolic risk. However, the incremental utility of CMI, LAP, and BAI in association with prevalent hypertension has not been well described in a population-based setting. We hypothesized that CMI, LAP, and BAI would provide important insight into hypertension risk.
Methods: Blood pressure (BP), fasting lipid profiles, and anthropometric parameters were recorded in a cross-sectional study of 11,400 participants (mean age, 54 years; 53% women) from China. Logistic regression models were used to assess associations of CMI, LAP, and BAI with prevalent hypertension. BAI was evaluated according to hip (cm)/[height (m)1.5]-18; LAP was calculated separately for men [(WC-65) × TG] and women [(WC-58) × TG]; and CMI was defined by TG/HDL-C × waist-to-height ratio.
Results: CMI, LAP, and BAI were independently correlated with higher SBP and DBP, with nonstandardized (B) coefficients ranging from 1.827 to 4.590 mmHg and 1.475 to 2.210 mmHg (all P < 0.001). After adjustment for hypertension risk factors and potential confounders, CMI, LAP, and BAI, modeled as continuous measures, carried hypertension odds (95% CI) of 1.356 (1.259-1.459), 1.631 (1.501-1.771), and 1.555 (1.454-1.662) in women, respectively, per SD increment. In men, each SD increase in CMI, LAP, and BAI experienced a 31%, 65%, and 53% higher hypertension risk, respectively. Moreover, among women, the odds ratio (95% CI) for hypertension were 2.318 (1.956-2.745), 3.548 (2.985-4.217), and 3.004 (2.537-3.557) in the 4th quartile vs the first quartile of CMI, LAP, and BAI, respectively. For men, the corresponding figures were 2.200 (1.838-2.635), 3.892 (3.238-4.677), and 3.288 (2.754-3.927), respectively.
Conclusion: Measurements of CMI, LAP, and BAI provide a more complete understanding of hypertension risk related to variation in body fat distribution and pinpoint hypertensive participants in great risk of cardiovascular disease in the future.
Keywords: Hypertension; adiposity; body adiposity index; cardiometabolic index; epidemiology; lipid accumulation product.
Similar articles
-
Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population.Clin Rheumatol. 2018 Aug;37(8):2221-2231. doi: 10.1007/s10067-018-4143-x. Epub 2018 May 16. Clin Rheumatol. 2018. PMID: 29770928
-
Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.Atherosclerosis. 2017 Nov;266:145-150. doi: 10.1016/j.atherosclerosis.2017.09.022. Epub 2017 Sep 22. Atherosclerosis. 2017. PMID: 29028482
-
Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China.BMC Cardiovasc Disord. 2018 Apr 10;18(1):62. doi: 10.1186/s12872-018-0798-0. BMC Cardiovasc Disord. 2018. PMID: 29631555 Free PMC article.
-
Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.Lipids Health Dis. 2023 Mar 15;22(1):41. doi: 10.1186/s12944-023-01802-6. Lipids Health Dis. 2023. PMID: 36922815 Free PMC article. Review.
-
Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis.J Diabetes Metab Disord. 2022 Aug 30;21(2):1943-1973. doi: 10.1007/s40200-022-01114-z. eCollection 2022 Dec. J Diabetes Metab Disord. 2022. PMID: 36404835 Free PMC article. Review.
Cited by
-
Non-linear associations of cardiometabolic index with insulin resistance, impaired fasting glucose, and type 2 diabetes among US adults: a cross-sectional study.Front Endocrinol (Lausanne). 2024 Feb 12;15:1341828. doi: 10.3389/fendo.2024.1341828. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38410697 Free PMC article.
-
Relationship Between Cardiometabolic Index and Insulin Resistance in Patients with Type 2 Diabetes.Diabetes Metab Syndr Obes. 2024 Jan 23;17:305-315. doi: 10.2147/DMSO.S449374. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38283637 Free PMC article.
-
Wakabayashi & Daimon cardiometabolic index as an indicator to assess risk in adults. A systematic review.Aten Primaria. 2024 Jan 12;56(5):102846. doi: 10.1016/j.aprim.2023.102846. Online ahead of print. Aten Primaria. 2024. PMID: 38218120 Free PMC article.
-
Relationship Between Cardiometabolic Index in Early Pregnancy and Hypertensive Disorder Complicating Pregnancy.Cureus. 2024 Jan 3;16(1):e51598. doi: 10.7759/cureus.51598. eCollection 2024 Jan. Cureus. 2024. PMID: 38205084 Free PMC article.
-
Association between cardiometabolic index and erectile dysfunction among US adults: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001-2004.Int J Impot Res. 2023 Dec 20. doi: 10.1038/s41443-023-00801-6. Online ahead of print. Int J Impot Res. 2023. PMID: 38123844
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
